201 related articles for article (PubMed ID: 28665353)
41. AMP-activated protein kinase selectively inhibited by the type II inhibitor SBI-0206965.
Dite TA; Langendorf CG; Hoque A; Galic S; Rebello RJ; Ovens AJ; Lindqvist LM; Ngoei KRW; Ling NXY; Furic L; Kemp BE; Scott JW; Oakhill JS
J Biol Chem; 2018 Jun; 293(23):8874-8885. PubMed ID: 29695504
[TBL] [Abstract][Full Text] [Related]
42. Promise and challenges for direct small molecule AMPK activators.
Olivier S; Foretz M; Viollet B
Biochem Pharmacol; 2018 Jul; 153():147-158. PubMed ID: 29408352
[TBL] [Abstract][Full Text] [Related]
43. AMPK is a direct adenylate charge-regulated protein kinase.
Oakhill JS; Steel R; Chen ZP; Scott JW; Ling N; Tam S; Kemp BE
Science; 2011 Jun; 332(6036):1433-5. PubMed ID: 21680840
[TBL] [Abstract][Full Text] [Related]
44. AMPK: an emerging drug target for diabetes and the metabolic syndrome.
Zhang BB; Zhou G; Li C
Cell Metab; 2009 May; 9(5):407-16. PubMed ID: 19416711
[TBL] [Abstract][Full Text] [Related]
45. The AMPK enzyme-complex: from the regulation of cellular energy homeostasis to a possible new molecular target in the management of chronic inflammatory disorders.
Antonioli L; Colucci R; Pellegrini C; Giustarini G; Sacco D; Tirotta E; Caputi V; Marsilio I; Giron MC; Németh ZH; Blandizzi C; Fornai M
Expert Opin Ther Targets; 2016; 20(2):179-91. PubMed ID: 26414111
[TBL] [Abstract][Full Text] [Related]
46. Elucidating the Activation Mechanism of AMPK by Direct Pan-Activator PF-739.
Aledavood E; Gheeraert A; Forte A; Vuillon L; Rivalta I; Luque FJ; Estarellas C
Front Mol Biosci; 2021; 8():760026. PubMed ID: 34805275
[TBL] [Abstract][Full Text] [Related]
47. Fluorinated N,N'-diarylureas as AMPK activators.
Sviripa V; Zhang W; Conroy MD; Schmidt ES; Liu AX; Truong J; Liu C; Watt DS
Bioorg Med Chem Lett; 2013 Mar; 23(6):1600-3. PubMed ID: 23414799
[TBL] [Abstract][Full Text] [Related]
48. Down-regulation of adenosine monophosphate-activated protein kinase activity: A driver of cancer.
He X; Li C; Ke R; Luo L; Huang D
Tumour Biol; 2017 Apr; 39(4):1010428317697576. PubMed ID: 28381161
[TBL] [Abstract][Full Text] [Related]
49. Fructose surges damage hepatic adenosyl-monophosphate-dependent kinase and lead to increased lipogenesis and hepatic insulin resistance.
Gugliucci A
Med Hypotheses; 2016 Aug; 93():87-92. PubMed ID: 27372863
[TBL] [Abstract][Full Text] [Related]
50. Activation of AMPK and its Impact on Exercise Capacity.
Niederberger E; King TS; Russe OQ; Geisslinger G
Sports Med; 2015 Nov; 45(11):1497-509. PubMed ID: 26186961
[TBL] [Abstract][Full Text] [Related]
51. Discovery of 3,5-Dimethylpyridin-4(1H)-one Derivatives as Activators of AMP-Activated Protein Kinase (AMPK).
Kuramoto K; Sawada Y; Ishibashi N; Yamada T; Nagashima T; Shin T
Chem Pharm Bull (Tokyo); 2020; 68(1):77-90. PubMed ID: 31902903
[TBL] [Abstract][Full Text] [Related]
52. Design, synthesis, and biological evaluation of 1,2,4-oxadiazole-containing pyrazolo[3,4-b]pyridinones as a new series of AMPKɑ1β1γ1 activators.
Xiao Z; Peng Y; Zheng B; Chang Q; Guo Y; Chen Z; Li Q; Hu G
Arch Pharm (Weinheim); 2021 Jul; 354(7):e2000458. PubMed ID: 33683726
[TBL] [Abstract][Full Text] [Related]
53. [Research progress of Adenosine 5'-monophosphate-activated protein kinase in the regulation of glycolipid metabolism].
Liu F; Wang Q; Qian Y; Zhang Y; Zhang B; Li H; Zou W
Sheng Wu Gong Cheng Xue Bao; 2019 Jun; 35(6):1021-1028. PubMed ID: 31231998
[TBL] [Abstract][Full Text] [Related]
54. Berberine Pretreatment Confers Cardioprotection Against Ischemia-Reperfusion Injury in a Rat Model of Type 2 Diabetes.
Chang W; Li K; Guan F; Yao F; Yu Y; Zhang M; Hatch GM; Chen L
J Cardiovasc Pharmacol Ther; 2016 Sep; 21(5):486-94. PubMed ID: 26846272
[TBL] [Abstract][Full Text] [Related]
55. Structural insights into the architecture and allostery of full-length AMP-activated protein kinase.
Zhu L; Chen L; Zhou XM; Zhang YY; Zhang YJ; Zhao J; Ji SR; Wu JW; Wu Y
Structure; 2011 Apr; 19(4):515-22. PubMed ID: 21481774
[TBL] [Abstract][Full Text] [Related]
56. Redox implications of AMPK-mediated signal transduction beyond energetic clues.
Cardaci S; Filomeni G; Ciriolo MR
J Cell Sci; 2012 May; 125(Pt 9):2115-25. PubMed ID: 22619229
[TBL] [Abstract][Full Text] [Related]
57. AMP-activated protein kinase: an emerging drug target to regulate imbalances in lipid and carbohydrate metabolism to treat cardio-metabolic diseases.
Srivastava RA; Pinkosky SL; Filippov S; Hanselman JC; Cramer CT; Newton RS
J Lipid Res; 2012 Dec; 53(12):2490-514. PubMed ID: 22798688
[TBL] [Abstract][Full Text] [Related]
58. Structural basis for compound C inhibition of the human AMP-activated protein kinase α2 subunit kinase domain.
Handa N; Takagi T; Saijo S; Kishishita S; Takaya D; Toyama M; Terada T; Shirouzu M; Suzuki A; Lee S; Yamauchi T; Okada-Iwabu M; Iwabu M; Kadowaki T; Minokoshi Y; Yokoyama S
Acta Crystallogr D Biol Crystallogr; 2011 May; 67(Pt 5):480-7. PubMed ID: 21543851
[TBL] [Abstract][Full Text] [Related]
59. Molecular characterization and expression of AMP-activated protein kinase in response to low-salinity stress in the Pacific white shrimp Litopenaeus vannamei.
Xu C; Li E; Xu Z; Wang S; Chen K; Wang X; Li T; Qin JG; Chen L
Comp Biochem Physiol B Biochem Mol Biol; 2016 Aug; 198():79-90. PubMed ID: 27095693
[TBL] [Abstract][Full Text] [Related]
60. Pharmacological Targeting of AMP-Activated Protein Kinase and Opportunities for Computer-Aided Drug Design.
Miglianico M; Nicolaes GA; Neumann D
J Med Chem; 2016 Apr; 59(7):2879-93. PubMed ID: 26510622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
